MENU
+Compare
MNPR
Stock ticker: NASDAQ
AS OF
Jun 24, 04:59 PM (EDT)
Price
$33.43
Change
+$1.60 (+5.03%)
Capitalization
194.65M

MNPR Monopar Therapeutics Inc Forecast, Technical & Fundamental Analysis

Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients... Show more

MNPR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for MNPR with price predictions
Jun 23, 2025

MNPR's RSI Oscillator ascends from oversold territory

The RSI Indicator for MNPR moved out of oversold territory on June 03, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 31 similar instances when the indicator left oversold territory. In of the 31 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

Following a +2 3-day Advance, the price is estimated to grow further. Considering data from situations where MNPR advanced for three days, in of 241 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on June 18, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on MNPR as a result. In of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for MNPR turned negative on June 23, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at .

MNPR moved below its 50-day moving average on June 06, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for MNPR crossed bearishly below the 50-day moving average on May 21, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MNPR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for MNPR entered a downward trend on June 10, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. MNPR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.632) is normal, around the industry mean (16.460). P/E Ratio (0.000) is within average values for comparable stocks, (58.911). MNPR's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.291). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (252.526).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MNPR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
MNPR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a clinical stage biopharmaceutical company, which engages in building a drug development pipeline of oncology therapeutics in late preclinical and clinical development stages

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1000 Skokie Boulevard
Phone
+1 847 388-0349
Employees
10
Web
https://www.monopartx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GLDIX32.47N/A
N/A
Gabelli Gold I
BMDSX20.09N/A
N/A
Baird Mid Cap Growth Investor
IVRSX28.27N/A
N/A
VY® CBRE Real Estate S
JBGAX58.85N/A
N/A
JHancock Blue Chip Growth A
LHCFX18.21N/A
N/A
Lord Abbett Health Care F

MNPR and Stocks

Correlation & Price change

A.I.dvisor tells us that MNPR and QNCX have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MNPR and QNCX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MNPR
1D Price
Change %
MNPR100%
-3.13%
QNCX - MNPR
32%
Poorly correlated
+1.54%
CVKD - MNPR
29%
Poorly correlated
-7.37%
AKBLF - MNPR
29%
Poorly correlated
N/A
BDRX - MNPR
26%
Poorly correlated
+6.22%
ZLAB - MNPR
25%
Poorly correlated
+4.23%
More